Novozymes Number One in Sustainability Yet Again; For the Third Year Running, Novozymes is Number One in the Dow Jones Sustainability Group Index - in Europe and on a Worldwide Level.

BAGSVAERD, Denmark, Sept. 5 /PRNewswire/ -- The results of the annual survey of 2,500 companies were announced today by Dow Jones Indexes, STOXX Limited and the SAM Group. The results form the basis for placing 300 companies from 22 countries in a global index and 178 companies from 13 countries in a pan-European index. In both indexes, Novozymes is number one in its field -- biotechnology and pharmaceutical industry.

Novozymes is a Danish biotech company and world leader in enzymes and microorganisms. For the third time in its three years as an independent listed company, Novozymes has achieved first place in the internationally acclaimed Dow Jones sustainability index, which evaluates companies in respect of environmental, social and economic aspects of their business.

See http://www.sustainability-indexes.com/

Novozymes A/S is a biotech-based world leader in enzymes and microorganisms for industrial use. Novozymes also applies its core competencies in selected pharmaceutical areas. With headquarters in Denmark, Novozymes employs more than 3,700 people, is represented in 27 countries, and sells its enzymes and microorganisms in more than 130 countries. The company's B-shares are listed on the Copenhagen Stock Exchange. For further company information, visit Novozymes on the Internet at http://www.novozymes.com/

CONTACT: Media Relations, Eva Louise Holm Petersen, +45-4442-3338, or Investor Relations, Michael Steen-Knudsen, +45-4442-6048, both of Novozymes

Web site: http://www.novozymes.com/ http://www.sustainability-indexes.com/